Antacids Market

Antacids Market by Dosage Form (Tablet, Liquid, and others), Distribution Channels (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-862
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 190
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global antacids market size is expected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the changing dietary habits.
 

Antacids Market Key Takeaways


Antacids are a group of medicines which helps to neutralize the acid reflux content present inside the stomach. They are largely used in treatment of acid indigestion, dyspepsia discomfort, stomach upset, and sour stomach. Antacids gives fast relief from heartburn. They are used for relieving the symptoms quickly because they start working in second. Antacids are present in liquid as well as in chewable tablets form and available in less price and without any prescription.

Growing prevalence of Gastro-Esophageal Reflux Diseases (GERD) projected to disturb the overall market over the forecast period. Based on the Gut journal, published by the International Foundation for Gastrointestinal Disorders, in 2017, the incidences of GERD was around 20% to 25% in North America, 22% in South America, 10% to 30% in the Middle East, 10% to 20% in Europe, and 5% to 7% in East Asia. Moreover, rising awareness of GERD among people is catering the market expansion. As per article published in the International Foundation for Gastrointestinal Disorders, in November 2018, the 19th Annual GERD Awareness Week gave information and support related to this condition. The International Foundation for Functional Gastrointestinal Disorders (IFFGD) heartens patients suffering from GERD-related symptoms, for their physician’s consultation.

However, the rising prevalence of heartburn is anticipated to hamper the market in coming years. Based on an article published in the Medical Xpress, in 2017, researchers from the University of Michigan recognized that around 21% of total U.S. population were affected by heartburn and acid reflux.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing demand of early diagnosis among people, rising focus on quality of drugs, and huge production rate are anticipated to fuel the market growth over the forecast period.
  • Rising awareness about early symptoms of gastrointestinal disease and increasing incidences of self-medication are driving the growth of the market.
  • Inexpensive antacids and side effects of drugs such as non-steroidal and anti-inflammatory drugs are key factors fuelling the market expansion over the forecast period.
  • Growing geriatric population and increasing incidences of gastroesophageal reflux disease are major factors responsible for propelling the market growth.
  • Change in lifestyle, irregular dietary habits, deskbound jobs, and poor quality of sleep are projected to boost the market growth in coming years.
  • Side effects of antacids such as milk-alkali syndrome, aluminum-intoxication, hypophosphatemia, constipation, osteomalacia, and dose-dependent rebound hyperacidity are expected to hamper the market growth over the forecast period.

Scope of the Report

The report on the global antacids market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Antacids Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Dosage Form (Tablet, Liquid, and others), Distribution Channels (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

GlaxoSmithKline plc.; Bayer AG; Boehringer Ingelheim International GmbH; Dr. Reddy’s Laboratories Ltd.; Sanofi; Reckitt Benckiser Group plc.; Sun Pharmaceuticals Ltd.; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble

 

Market Segment Insights

Tablet segment is projected to hold a major market share
On the basis of dosage form, the antacids market is divided into tablet, liquid, and others. The tablet segment is expected to hold a key share of the market during the forecast period. In the market tablets are present with many flavors to increase patient adherence on the medicine which is projected to fuel the segment growth in the coming years. Tablets offers particular amount of dosage to the patients as compared to other forms of dosage. Also tablets are easy to store which is propelling the demand of antacids in the tablet forms.

On the other hand, the liquid segment is anticipated to expand at a rapid pace during the forecast period. Major market players such as Pfizer Inc.; GlaxoSmithKline plc.; and Dabur provides antacids in liquid form which drives the segment growth. Liquid antacids are available in flavored form. Because of this children and geriatric population prefers liquid antacids which boosts the growth of the segment.
 

Antacids Market By Dosage Form


Online pharmacy segment is expected to expand at a rapid pace
Based on distribution channels, the antacids market is segmented into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment is expected to account for a key share of the market in the coming years owing to its easy availability and accessibility.

However, the online pharmacy segment is anticipated to expand at a rapid pace during the forecast period due to growing awareness among people. Based on survey conducted by the Alliance, in 2017, for Safe Online Pharmacies (ASOP Global), 35% of participants from Canada had bought prescription medicines from online pharmacy. People are choosing online pharmacies due to beneficial offers such as availability of drugs, price discounts, and home delivery services.

Asia Pacific is expected to dominate the market
On the basis of regions, the antacids market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to availability of effective treatment methods and increasing disposable income. Moreover, high unmet clinical needs and awareness about the availability of these products among consumer are anticipated to drive the regional market growth. Also, presence of key market players such as GlaxoSmithKline plc.; Pfizer Inc.; Abbott are propelling the regional market expansion.

However, the market of North America is expected to exhibit a rapid growth rate in the coming years owing to growing prevalence of digestive disorder along with consumer awareness about antacid products. The presence of developed countries in region is driving the regional market growth.
 

Antacids Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Antacids Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Antacids Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Antacids Market - Supply Chain
  4.5. Global Antacids Market Forecast
     4.5.1. Antacids Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Antacids Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Antacids Market Absolute $ Opportunity
5. Global Antacids Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Antacids Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Antacids Demand Share Forecast, 2019-2026
6. North America Antacids Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Antacids Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Antacids Demand Share Forecast, 2019-2026
7. Latin America Antacids Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Antacids Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Antacids Demand Share Forecast, 2019-2026
8. Europe Antacids Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Antacids Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Antacids Demand Share Forecast, 2019-2026
9. Asia Pacific Antacids Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Antacids Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Antacids Demand Share Forecast, 2019-2026
10. Middle East & Africa Antacids Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Antacids Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Antacids Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Antacids Market: Market Share Analysis
  11.2. Antacids Distributors and Customers
  11.3. Antacids Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. GlaxoSmithKline plc.
     11.4.2. Bayer AG
     11.4.3. Boehringer Ingelheim International GmbH
     11.4.4. Dr. Reddy’s Laboratories Ltd.
     11.4.5. Sanofi
     11.4.6. Reckitt Benckiser Group plc.
     11.4.7. Sun Pharmaceuticals Ltd.
     11.4.8. Takeda Pharmaceutical Company Limited
     11.4.9. Pfizer Inc.
     11.4.10. Procter & Gamble

Segments Covered in the Report
The global antacids market has been segmented on the basis of

Dosage Form

  • Tablet
  • Liquid
  • Others

Distribution channels

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • GlaxoSmithKline plc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • Sanofi
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceuticals Ltd.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Procter & Gamble

Key players competing in the antacids market include GlaxoSmithKline plc.; Bayer AG; Boehringer Ingelheim International GmbH; Dr. Reddy’s Laboratories Ltd.; Sanofi; Reckitt Benckiser Group plc.; Sun Pharmaceuticals Ltd.; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble.

Major market players are adopting several business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase/enhance their market shares. For instance, in 2016, Dexilant (Dexlansoprazole) was launched by Takeda Pharmaceutical Company Limited. It was company’s first approved proton pump inhibitor that uses dual delayed-release technology for GERD patients.

Antacids Market By Key Players

 

Buy Report